These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7371359)

  • 1. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia.
    Calvo R; Carlos R; Erill S
    Pharmacology; 1982; 24(4):248-52. PubMed ID: 7089046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unchanged protein binding of penbutolol in renal insufficiency: a possible role of carbamylation.
    Aguirre C; Calvo R; Rodriguez-Sasiain JM
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):31-4. PubMed ID: 8444514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamylation is a competitor of glycation for protein modification in vivo.
    Nicolas C; Jaisson S; Gorisse L; Tessier FJ; Niquet-Léridon C; Jacolot P; Pietrement C; Gillery P
    Diabetes Metab; 2018 Mar; 44(2):160-167. PubMed ID: 28690125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylation of proteins and sulfacetamide free fraction in serum in experimentally-induced high blood urea states.
    Erill S; du Souich P; Courteau H
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):45-56. PubMed ID: 4081313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein carbamylation links inflammation, smoking, uremia and atherogenesis.
    Wang Z; Nicholls SJ; Rodriguez ER; Kummu O; Hörkkö S; Barnard J; Reynolds WF; Topol EJ; DiDonato JA; Hazen SL
    Nat Med; 2007 Oct; 13(10):1176-84. PubMed ID: 17828273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired biological activity of erythropoietin by cyanate carbamylation.
    Mun KC; Golper TA
    Blood Purif; 2000; 18(1):13-7. PubMed ID: 10686438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting drug binding in plasma of elderly patients.
    Wallace S; Whiting B
    Br J Clin Pharmacol; 1976 Apr; 3(2):327-30. PubMed ID: 973967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding of salicylate in uremic and normal plasma.
    Borgå O; Cederlöf IO; Ringberger VA; Norlin A
    Clin Pharmacol Ther; 1976 Oct; 20(4):464-75. PubMed ID: 975718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procaine hydrolysis defect in uraemia does not appear to be due to carbamylation of plasma esterases.
    Calvo R; Carlos R; Erill S
    Eur J Clin Pharmacol; 1983; 24(4):533-5. PubMed ID: 6861870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyanate in the induction of vascular dysfunction during uremia: more than protein carbamylation?
    Hawkins CL
    Kidney Int; 2014 Nov; 86(5):875-7. PubMed ID: 25360490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.
    Clegg LS; Lindup WE
    Biochem Pharmacol; 1982 Sep; 31(17):2791-4. PubMed ID: 7138574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction formula for carbamylated haemoglobin in diabetic uraemic patients.
    Hammouda AM; Mady GE
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    Biochem Pharmacol; 1982 Nov; 31(21):3483-7. PubMed ID: 7150368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting drug-protein binding in the plasma of newborn infants.
    Wallace S
    Br J Clin Pharmacol; 1976 Jun; 3(3):510-2. PubMed ID: 973977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.